St Louis Trust’s GSK GSK Stock Holding History

St Louis Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,110	Closed	-$354K	–	106
2021 Q2	$354K	Hold	7,110	–	–	0.09%	78
2021 Q1	$317K	Buy	+7,110	New	+$323K	0.08%	81
2020 Q4	–	Sell	-11,106	Closed	-$523K	–	77
2020 Q3	$523K	Hold	11,106	–	–	0.17%	66
2020 Q2	$566K	Hold	11,106	–	–	0.17%	61
2020 Q1	$526K	Hold	11,106	–	–	0.2%	58
2019 Q4	$652K	Hold	11,106	–	–	0.19%	54
2019 Q3	$593K	Hold	11,106	–	–	0.18%	55
2019 Q2	$556K	Hold	11,106	–	–	0.18%	56
2019 Q1	$580K	Hold	11,106	–	–	0.19%	55
2018 Q4	$530K	Hold	11,106	–	–	0.19%	56
2018 Q3	$558K	Hold	11,106	–	–	0.19%	60
2018 Q2	$560K	Hold	11,106	–	–	0.19%	70
2018 Q1	$542K	Buy	+11,106	New	+$517K	0.19%	77

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

St Louis Trust's GSK Position: Q3 2021 in Review

St Louis Trust sold out of GSK (GSK) in Q3 2021, closing a stake of 7,110 shares — an estimated $354K sold.

St Louis Trust first reported a position in GSK in Q1 2018 and held it in 13 quarters. The position peaked at $652K in Q4 2019. 792 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

St Louis Trust reported no remaining GSK position as of Q3 2021 after selling out during the quarter.
St Louis Trust sold 7,110 GSK shares in Q3 2021, an estimated $354K.
St Louis Trust first reported a position in GSK in Q1 2018 and held it in 13 quarters.
St Louis Trust's GSK position peaked at $652K in Q4 2019.
792 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on St Louis Trust's 13F filing for Q3 2021, filed 12 Nov 2021.